Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma

Molecular and Cellular Proteomics

Volumn 10, Issue 7, 2011, Pages

  Chen, Rui ^a   Tan, Yexiong ^b   Wang, Min ^b   Wang, Fangjun ^a   Yao, Zhenzhen ^b   Dong, Liwei ^b   Ye, Mingliang ^a   Wang, Hongyang ^b   Zou, Hanfa ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; GALECTIN 3; GLYCOPEPTIDE; GLYCOPROTEIN; SOMATOMEDIN BINDING PROTEIN 3; THROMBOSPONDIN 1; TRYPSIN; TUMOR MARKER; CARRIER PROTEIN; IGFBP3 PROTEIN, HUMAN; LGALS3BP PROTEIN, HUMAN; TUMOR ANTIGEN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; AFFINITY CHROMATOGRAPHY; BLOOD; CASE CONTROL STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; STANDARD;

ADULT; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, AFFINITY; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL;

EID: 84855188603     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.006445     Document Type: Article

References (57)

1. Ong, S. E., and Mann, M. (2005) Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1, 252-262
2. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope- coded affinity tags. Nat. Biotech. 17, 994-999
3. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
4. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
5. Bondarenko, P. V., Chelius, D., and Shaler, T. A. (2002) Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Chem. 74, 4741-4749
6. Liu, H., Sadygov, R. G., and Yates, J. R., 3rd (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201
7. Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F., Romano, P. R., Fimmel, C., Tennant, B. C., London, W. T., Evans, A. A., Blumberg, B. S., Dwek, R. A., Mattu, T. S., and Mehta, A. S. (2005) Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. U.S.A. 102, 779-784
8. Anderson, N. L., and Anderson, N. G. (2002) The human plasma proteome - History, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867
9. Gahmberg, C. G., and Tolvanen, M. (1996) Why mammalian cell surface proteins are glycoproteins. Trends Biochem. Sci. 21, 308-311
10. Yang, Z., and Hancock, W. S. (2004) Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J. Chromatogr. A 1053, 79-88 (Pubitemid 39369762)
11. Wang, Y., Ao, X., Vuong, H., Konanur, M., Miller, F. R., Goodison, S., and Lubman, D. M. (2008) Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach. J. Proteome Res. 7, 4313-4325
12. Plavina, T., Wakshull, E., Hancock, W. S., and Hincapie, M. (2007) Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery. J. Proteome Res. 6, 662-671 (Pubitemid 46340170)
13. Gong, Y., Li, X., Yang, B., Ying, W., Li, D., Zhang, Y., Dai, S., Cai, Y., Wang, J., He, F., and Qian, X. (2006) Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J. Proteome Res. 5, 1379-1387 (Pubitemid 43865808)
14. Zhang, H., Li, X. J., Martin, D. B., and Aebersold, R. (2003) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21, 660-666
15. Bantscheff, M., Schirle, M., Sweetman, G., Rick, J., and Kuster, B. (2007) Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem. 389, 1017-1031
16. Schiess, R., Mueller, L. N., Schmidt, A., Mueller, M., Wollscheid, B., and Aebersold, R. (2009) Analysis of Cell Surface Proteome Changes via Label-free, Quantitative Mass Spectrometry. Mol. Cell. Proteomics 8, 624-638
17. Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L., Pierce, K. G., Mendoza, A., Sevinsky, J. R., Resing, K. A., and Ahn, N. G. (2005) Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics 4, 1487-1502
18. Whelan, S. A., Lu, M., He, J. B., Yan, W. H., Saxton, R. E., Faull, K. F., Whitelegge, J. P., and Chang, H. R., (2009) Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers, J Proteome Res. 8, 4151-4160
19. Zhou, Y., Aebersold, R., and Zhang, H. (2007) Isolation of N-linked glycopeptides from plasma. Anal. Chem. 79, 5826-5837
20. Wang, F., Dong, J., Jiang, X., Ye, M., and Zou, H. (2007) Capillary trap column with strong cation-exchange monolith for automated shotgun proteome analysis. Anal. Chem. 79, 6599-6606
21. Nesvizhskii, A. I., and Aebersold, R. (2005) Interpretation of shotgun proteomic data - The protein inference problem. Mol. Cell. Proteomics 4, 1419-1440
22. Chen, R., Jiang, X., Sun, D., Han, G., Wang, F., Ye, M., Wang, L., and Zou, H. (2009) Glycoproteomics Analysis of Human Liver Tissue by Combination of Multiple Enzyme Digestion and Hydrazide Chemistry. J. Proteome Res. 8, 651-661
23. Sun, B., Ranish, J. A., Utleg, A. G., White, J. T., Yan, X., Lin, B., and Hood, L. (2007) Shotgun glycopeptide capture approach coupled with mass Spectrometry for comprehensive glycoproteomics. Mol. Cell. Proteomics 6, 141-149
24. McDonald, C. A., Yang, J. Y., Marathe, V., Yen, T. Y., and Macher, B. A. (2009) Combining Results from Lectin Affinity Chromatography and Glycocapture Approaches Substantially Improves the Coverage of the Glycoproteome. Mol. Cell. Proteomics 8, 287-301
25. Wang, G., Wu, W. W., Zeng, W., Chou, C. L., and Shen, R. F. (2006) Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: Reproducibility, linearity, and application with complex proteomes. J. Proteome Res. 5, 1214-1223
26. Zybailov, B., Coleman, M. K., Florens, L., and Washburn, M. P. (2005) Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal. Chem. 77, 6218-6224
27. Burnett, W. (1960) An assessment of the value of serum cholinesterase as a liver function test and in the diagnosis of jaundice. Gut 1, 294-302
28. McKeownLongo, P. J., and Panetti, T. S. (1996) Structure and function of vitronectin. Trends Glycosci. Glyc. 8, 327-340
29. Inuzuka, S., Ueno, T., Torimura, T., Tamaki, S., Sakata, R., Sata, M., Yoshida, H., and Tanikawa, K. (1992) Vitronectin in liver disorders - Biomedical and immunohistochemical studies. Hepatology 15, 629-636
30. Edwards, S., Lalor, P. F., Tuncer, C., and Adams, D. H. (2006) Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta 3-independent manner. Brit. J. Cancer 95, 1545-1554
31. Paradis, V., Degos, F., Dargère, D., Pham, N., Belghiti, J., Degott, C., Janeau, J. L., Bezeaud, A., Delforge, D., Cubizolles, M., Laurendeau, I., and Bedossa, P. (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41, 40-47
32. Podor, T. J., Campbell, S., Chindemi, P., Foulon, D. M., Farrell, D. H., Walton, P. D., Weitz, J. I., and Peterson, C. B. (2002) Incorporation of vitronectin into fibrin clots - Evidence for a binding interaction between vitronectin and gamma A/gamma ' fibrinogen. J. Biol. Chem. 277, 7520-7528
33. Comunale, M. A., Wang, M., Hafner, J., Krakover, J., Rodemich, L., Kopenhaver, B., Long, R. E., Junaidi, O., Bisceglie, A. M., Block, T. M., and Mehta, A. S. (2009) Identification and Development of Fucosylated Glycoproteins as Biomarkers of Primary Hepatocellular Carcinoma. J. Proteome Res. 8, 595-602
34. Taketa, K., Sekiya, C., Namiki, M., Akamatsu, K., Ohta, Y., Endo, Y., and Kosaka, K. (1990) Lectin-reactive Profiles of Alpha-fetoprotein Characterizing Hepatocellular-carcinoma and Related Conditions. Gastroenterology 99, 508-518 (Pubitemid 20219108)
35. Bosch, F. X., Ribes, J., Diaz, M., and Cleries, R. (2004) Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127, S5-S16 (Pubitemid 39423365)
36. Chen, D. S., Sung, J. L., Sheu, J. C., Lai, M. Y., How, S. W., Hsu, H. C., Lee, C. S., and Wei, T. C. (1984) Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 86, 1404-1409
37. Buamah, P. K., Gibb, I., Bates, G., and Ward, A. M. (1984) Serum alpha-fetoprotein heteogeneity as a means of differentiatting between primary heaptocellular carcinoma and heaptic secondaries. Clin. Chim. Acta 139, 313-316
38. Liu, B., Lee, K. W., Anzo, M., Zhang, B., Zi, X., Tao, Y., Shiry, L., Pollak, M., Lin, S., and Cohen, P. (2007) Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene 26, 1811-1819 (Pubitemid 46426204)
39. Zhu, W., Shiojima, I., Ito, Y., Li, Z., Ikeda, H., Yoshida, M., Naito, A. T., Nishi, J., Ueno, H., Umezawa, A., Minamino, T., Nagai, T., Kikuchi, A., Asashima, M., and Komuro, I. (2008) IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 454, 345-349
40. Neuhouser, M. L., Schenk, J., Song, Y. J., Tangen, C. M., Goodman, P. J., Pollak, M., Penson, D. F., Thompson, I. M., and Kristal, A. R. (2008) Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate 68, 1477-1486
41. Fletcher, O., Gibson, L., Johnson, N., Altmann, D. R., Holly, J. M. P., Ashworth, A., Peto, J., and Silva, I. D. (2005) Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: A systematic review. Cancer Epidem. Biomar. 14, 2-19
42. Allen, N. E., Roddam, A. W., Allen, D. S., Fentiman, I. S., Silva, I. D., Peto, J., Holly, J. M. P., and Key, T. J. (2005) A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Brit. J. Cancer 92, 1283-1287
43. London, S. J., Yuan, J. M., Travlos, G. S., Gao, Y. T., Wilson, R. E., Ross, R. K., and Yu, M. C. (2002) Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J. Nat.l Cancer Inst. 94, 749-754
44. Hanafusa, T., Yumoto, Y., Nouso, K., Nakatsukasa, H., Onishi, T., Fujikawa, T., Taniyama, M., Nakamura, S., Uemura, M., Takuma, Y., Yumoto, E., Higashi, T., and Tsuji, T. (2002) Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett. 176, 149-158 (Pubitemid 34136014)
45. Iacobelli, S., Arnò, E., D'Orazio, A., and Coletti, G. (1986) Detection of antigens recognized by a novel monoclonal-antibody in tissue and serum from patients with breast cancer. Cancer Res. 46, 3005-3010
46. Inohara, H., Akahani, S., Koths, K., and Raz, A. (1996) Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res. 56, 4530-4534 (Pubitemid 26330466)
47. Fukaya, Y., Shimada, H., Wang, L. C., Zandi, E., and DeClerck, Y. A. (2008) Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma. J. Biol. Chem. 283, 18573-18581
48. Iacobelli, S., Sismondi, P., Giai, M., Degidio, M., Tinari, N., Amatetti, C., Distefano, P., and Natoli, C. (1994) Prognostic value of a novel circulation serum 90K antigen in breast cancer. Brit.J. Cancer 69, 172-176 (Pubitemid 24021843)
49. Marchetti, A., Tinari, N., Buttitta, F., Chella, A., Angeletti, C. A., Sacco, R., Mucilli, F., Ullrich, A., and Iacobelli, S. (2002) Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I nonsmall cell lung cancer patients. Cancer Res. 62, 2535-2539 (Pubitemid 34462731)
50. Zeimet, A. G., Natoli, C., Herold, M., Fuchs, D., Windbichler, G., Daxenbichler, G., Iacobelli, S., Dapunt, O., and Marth, C. (1996) Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Int. J. Cancer 68, 34-38 (Pubitemid 26354575)
51. Zambelli, D., Zuntini, M., Nardi, F., Manara, M. C., Serra, M., Landuzzi, L., Lollini, P. L., Ferrari, S., Alberghini, M., Llombart-Bosch, A., Piccolo, E., Iacobelli, S., Picci, P., and Scotlandi, K. (2010) Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). Inter. J. Cancer 126, 41-52
52. Kittl, E. M., Hofmann, J., Hartmann, G., Sebesta, C., Beer, F., Bauer, K., and Huber, K. R. (2000) Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection. Clin. Chem. Lab. Med. 38, 205-208
53. Correale, M., Giannuzzi, V., Iacovazzi, P. A., Valenza, M. A., Lanzillotta, S., Abbate, I., Quaranta, M., Caruso, M. L., Elba, S., and Manghisi, O. G. (1999) Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis. Anticancer Res. 19, 3469-3472
54. Esemuede, N., Lee, T., Pierre-Paul, D., Sumpio, B. E., and Gahtan, V. (2004) The role of thrombospondin-1 in human disease. J. Surg.Res. 122, 135-142 (Pubitemid 39441244)
55. Murphy-Ullrich, J. E., and Poczatek, M. (2000) Activation of latent TGF-beta by thrombospondin-1: Mechanisms and physiology. Cytokine Growth Factor Rev. 11, 59-69 (Pubitemid 30169726)
56. Tuszynski, G. P., Smith, M., Rothman, V. L., Capuzzi, D. M., Joseph, R. R., Katz, J., Besa, E. C., Treat, J., and Switalska, H. I. (1992) Thrombospondin levels in patients with malignancy. Thromb. Haemostasis 67, 607-611
57. Yamashita, Y., Kurohiji, T., Tuszynski, G. P., Sakai, T., and Shirakusa, T. (1998) Plasma thrombospondin levelsin patients with colorectal carcinoma. Cancer 82, 632-638 (Pubitemid 28090272)